Antibody-Induced Internalization of HIV-1 Env Proteins Limits Surface Expression of the Closed Conformation of Env.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 19 02 2019
accepted: 16 03 2019
pubmed: 22 3 2019
medline: 24 6 2020
entrez: 22 3 2019
Statut: epublish

Résumé

To minimize immune responses against infected cells, HIV-1 limits the surface expression of its envelope glycoprotein (Env). Here, we demonstrate that this mechanism is specific for the Env conformation and affects the efficiency of antibody-dependent cellular cytotoxicity (ADCC). Using flow cytometry and confocal microscopy, we show that broadly neutralizing antibodies (bNAbs) targeting the "closed" conformation of Env induce its internalization from the surface. In contrast, non-neutralizing antibodies (nNAbs) are displayed on the cell surface for prolonged period of times. The bNAb-induced Env internalization can be decreased by blocking dynamin function, which translates into higher susceptibilities of infected cells to ADCC. Our results suggest that antibody-mediated Env internalization is a mechanism used by HIV-1 to evade immune responses against the "closed" conformation of Env expressed on HIV-1-infected cells.

Identifiants

pubmed: 30894474
pii: JVI.00293-19
doi: 10.1128/JVI.00293-19
pmc: PMC6532100
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
HIV Antibodies 0
env Gene Products, Human Immunodeficiency Virus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI150471
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI095098
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI129769
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM116654
Pays : United States
Organisme : NIGMS NIH HHS
ID : P01 GM056550
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI120756
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121135
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI098485
Pays : United States
Organisme : CIHR
ID : 352417
Pays : Canada
Organisme : NIAID NIH HHS
ID : R01 AI116274
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Cell Biol. 1999 Jul 12;146(1):29-44
pubmed: 10402458
J Infect Dis. 1999 Oct;180(4):1338-41
pubmed: 10479168
J Virol. 2001 Jan;75(1):278-91
pubmed: 11119598
J Biol Chem. 2001 May 25;276(21):17887-94
pubmed: 11359789
J Gen Virol. 2003 Jan;84(Pt 1):93-7
pubmed: 12533704
J Gen Virol. 2003 Apr;84(Pt 4):939-48
pubmed: 12655095
J Virol. 2003 Jun;77(12):6931-45
pubmed: 12768012
Science. 2003 Jun 27;300(5628):2065-71
pubmed: 12829775
Virology. 2004 Oct 10;328(1):62-73
pubmed: 15380359
J Virol. 2005 Mar;79(6):3865-72
pubmed: 15731282
J Exp Med. 2005 May 2;201(9):1407-19
pubmed: 15867093
Vet Microbiol. 2006 Mar 31;113(3-4):257-63
pubmed: 16326036
J Gen Virol. 2006 Jun;87(Pt 6):1685-90
pubmed: 16690934
Mol Biol Cell. 2007 Feb;18(2):414-25
pubmed: 17108326
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7505-10
pubmed: 21502492
J Virol. 2011 Jul;85(14):6906-12
pubmed: 21593181
Nature. 2011 Sep 22;477(7365):466-70
pubmed: 21849977
Nat Rev Mol Cell Biol. 2012 Jan 11;13(2):75-88
pubmed: 22233676
J Virol. 2012 Mar;86(6):3014-26
pubmed: 22238299
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
PLoS Pathog. 2012;8(6):e1002739
pubmed: 22719248
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Immunity. 2012 Sep 21;37(3):412-25
pubmed: 22999947
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4351-6
pubmed: 23426631
PLoS Pathog. 2013;9(4):e1003278
pubmed: 23592992
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12438-43
pubmed: 23757493
J Virol. 2014 Mar;88(5):2633-44
pubmed: 24352444
J Virol. 2014 Jun;88(11):6031-46
pubmed: 24623433
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6425-30
pubmed: 24733916
Immunity. 2014 May 15;40(5):657-68
pubmed: 24768347
J Virol Methods. 2014 Nov;208:107-14
pubmed: 25125129
J Vis Exp. 2014 Sep 14;(91):51995
pubmed: 25286159
Science. 2014 Nov 7;346(6210):759-63
pubmed: 25298114
J Virol. 2015 Jan;89(1):545-51
pubmed: 25339767
Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7575-80
pubmed: 26034275
PLoS One. 2015 Jun 23;10(6):e0131430
pubmed: 26102354
J Virol. 2015 Oct;89(20):10648-55
pubmed: 26269175
Curr HIV Res. 2016;14(1):9-23
pubmed: 26310828
Cell Host Microbe. 2015 Sep 9;18(3):354-62
pubmed: 26355218
J Virol. 2015 Dec 04;90(4):2127-34
pubmed: 26637462
J Virol. 2015 Dec 30;90(6):2993-3002
pubmed: 26719277
EBioMedicine. 2015 Dec 09;3:122-134
pubmed: 26870823
Nat Commun. 2016 Mar 03;7:10844
pubmed: 26936020
J Virol. 2016 Sep 12;90(19):8395-409
pubmed: 27384653
AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1089-1096
pubmed: 27487965
EBioMedicine. 2016 Oct;12:208-218
pubmed: 27633463
MBio. 2016 Oct 25;7(5):
pubmed: 27795397
J Virol. 2017 May 12;91(11):
pubmed: 28331088
J Virol. 2017 Jun 26;91(14):
pubmed: 28468888
J Virol. 2017 Jul 27;91(16):
pubmed: 28615199
Cell. 2017 Aug 10;170(4):637-648.e10
pubmed: 28757252
Trends Microbiol. 2018 Apr;26(4):253-265
pubmed: 29162391
J Virol. 2018 Feb 12;92(5):
pubmed: 29212940
Virology. 2018 Feb;515:38-45
pubmed: 29248757
MBio. 2018 Mar 20;9(2):
pubmed: 29559570
Elife. 2018 Mar 21;7:
pubmed: 29561264
J Virol. 2018 Jun 13;92(13):
pubmed: 29669829
AIDS. 2018 Nov 13;32(17):2439-2451
pubmed: 30234611
J Virol. 2019 Jan 17;93(3):
pubmed: 30429344
PLoS Biol. 2019 Jan 16;17(1):e3000114
pubmed: 30650070
J Immunol. 1996 Sep 1;157(5):2168-73
pubmed: 8757343
J Biol Chem. 1997 May 16;272(20):13419-25
pubmed: 9148966
J Biol Chem. 1998 Jun 19;273(25):15773-8
pubmed: 9624176

Auteurs

Sai Priya Anand (SP)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.

Jonathan R Grover (JR)

Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, USA.

William D Tolbert (WD)

Infectious Diseases Division, Department of Medicine of Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.

Jérémie Prévost (J)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.

Jonathan Richard (J)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.

Shilei Ding (S)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.

Sophie Baril (S)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.

Halima Medjahed (H)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.

David T Evans (DT)

Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Wisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin, USA.

Marzena Pazgier (M)

Infectious Diseases Division, Department of Medicine of Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.

Walther Mothes (W)

Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, USA.

Andrés Finzi (A)

Centre de Recherche du CHUM, Montreal, Quebec, Canada andres.finzi@umontreal.ca.
Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH